Shanghai, China

Junzhen Zhang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Inventive Journey of Junzhen Zhang

Introduction

Junzhen Zhang, an innovative inventor based in Shanghai, China, has made significant contributions to the field of medicine with his patented work. His focus on developing pharmaceutical solutions has paved the way for potential advancements in therapeutic agents.

Latest Patents

Zhang holds a patent for a compound identified as a 1,2,4-triazine-3-amine derivative. This patent encompasses not only the compound itself but also its preparation method and its application in medicine. Specifically, the patent details the use of the derivative as an Aor Areceptor antagonist, targeting medical conditions that can be treated by inhibiting these receptors. The comprehensive description of this invention outlines various substituents represented in the general formula, showcasing the compound's versatility and potential effectiveness in medical treatments.

Career Highlights

Throughout his career, Junzhen Zhang has been associated with prominent companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His involvement with these organizations has allowed him to leverage his expertise in developing innovative medical solutions, contributing to the advancement of pharmaceutical research and development.

Collaborations

Zhang has worked alongside notable colleagues, including Biao Lu and Fangfang Jin. This collaboration not only highlights his ability to work effectively in a team but also underscores the importance of partnership in driving innovation within the pharmaceutical sector.

Conclusion

Junzhen Zhang's dedication to advancing medical science through his inventive work exemplifies the impact that a single inventor can have on the industry. With his patent focusing on a 1,2,4-triazine-3-amine derivative, he continues to be a key figure in pharmaceutical research, contributing to the development of therapies that have the potential to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…